mTORC1 is activated in almost all (95%) of primary AML samples, as documented by phosphorylation of p70S6K and 4E-BP1 at Thr 389 and Thr 37/46, respectively [107, 108]. Here, EIF4EBP1 is linked to acute myeloid leukemia.